Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV
<p>Abstract</p> <p>To determine the efficacy and safety of adding ezetimibe to maximally tolerated lipid lowering therapy in patients with HIV dyslipidemia.</p> <p>Retrospective analysis of lipid parameters was conducted for 33 patients with HIV who had been prescribed...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-06-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.lipidworld.com/content/6/1/15 |